Stock Analysis
DOCS (DOCS) Stock Analysis
DOCS (DOCS) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
DOCS (DOCS) currently has an AIQ Score of 66/100, indicating a neutral setup. Momentum is the strongest factor at 78/100. Value is the weakest current factor at 46/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
DOCS at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $32.76 |
| AIQ Score | 66/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $4.93B |
| P/E Ratio (TTM) | 29.61 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $0.13 |
| Revenue (quarter ended 2026-06-30) | $156.62M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.21 |
| Volume | 2.2M |
| 52-week range | $17.15-$67.46 |
| RSI 14 | 69.69 |
| 50-Day SMA | $28.16 |
| 200-Day SMA | $25.59 |
| Analyst Price Target | — |
| Next Earnings | — |
DOCS
Leader
Strong Relative Position
Latest quote
- Momentum78
- Value46
- Quality77
- Risk resilience64
- Sentiment—
DOCS Stock Analysis Summary
DOCS (DOCS) currently has an AIQ Score of 66/100, indicating a neutral setup. Momentum is the strongest factor at 78/100. Value is the weakest current factor at 46/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, DOCS has AIQ Score of 66/100 with Momentum base of 78/100 and fading Value at 46/100. Wait for component alignment before adding exposure.
Momentum (78/100) leads while Value (46/100) lags. This cross-factor spread creates entry timing uncertainty.
Sector · -2.59% stock move · DOCS classified in its covered industry.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is DOCS Bullish or Bearish Right Now?
DOCS currently has a neutral overall setup. Momentum is the strongest factor at 78/100, while Value is weakest at 46/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 77/100.
- - Momentum is constructive at 78/100.
- - Risk Resilience is supportive at 64/100.
- - Price is +19.44% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (36 vs 4).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
DOCS's Technical Analysis Consensus is currently Strong Buy, with 36 buy, 5 neutral, and 4 sell votes. DOCS's 14-day RSI is 69.69, which places the stock in a constructive momentum range. DOCS's beta is 1.21, indicating greater market sensitivity than the broad market.
What Changed in DOCS?
The largest recent change in DOCS is Momentum moving down by 2.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the DOCS Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
DOCS Decision Framework
Public evidence layers, setup checks, and risk context for DOCS.
DOCS (DOCS) Stock Analysis
DOCS has an AIQ Score of 66/100 in a Neutral regime. Momentum is strongest at 78/100. Beta is not shown in the current snapshot. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | DOCS is in a Neutral AIQ regime with score 66/100. |
| Signal Conflict | The primary conflict is that momentum leads at 78/100 while value lags at 46/100. |
| Factor Evidence | Momentum 78/100 · Value 46/100 · Quality 77/100 · Risk 64/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 78/100.
Momentum is 78/100 and RSI (14) is 69.7.
DOCS is in a Neutral regime at 66/100.
Risk factor is 64/100 and annual volatility 64.63%.
Current conflict: momentum leads at 78/100 while value lags at 46/100.
DOCS Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
DOCS Fundamentals
DOCS valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
DOCS Technical Analysis
DOCS technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
DOCS Stock Catalysts
Track DOCS earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
DOCS Dividend Analysis
DOCS dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
DOCS Financial Data
DOCS revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
DOCS Risk Analysis
DOCS volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
DOCS Stock News
DOCS stock news, market tone, recent headlines, and catalyst context.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching DOCS
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for DOCS
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
DOCS Stock FAQ
What is DOCS stock price today?
DOCS's current stock price is $32.76. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is DOCS bullish or bearish right now?
DOCS's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is DOCS's market cap?
DOCS's market cap is $4.93B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is DOCS's current P/E ratio?
DOCS's current P/E ratio is 29.61 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is DOCS's RSI?
DOCS's 14-day RSI is 69.69 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is DOCS above its 50-day and 200-day moving averages?
DOCS is 19.44% from its 50-day SMA and 31.44% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is DOCS's next earnings date?
DOCS's next earnings date is a key event to check before making a decision. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does DOCS pay a dividend?
DOCS's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.